Results 121 to 130 of about 1,213 (179)

Hemolytic Disease of Fetus and Newborn: A 24-Year Nationwide Cohort Study on Incidence, Management, and Outcomes

open access: yesClinical and Experimental Obstetrics & Gynecology
Background: Hemolytic disease of the fetus and newborn (HDFN) can cause severe prenatal and postnatal outcomes. The main objective of this study is to characterize the clinical impact of HDFN on pregnant women and their newborns.
Noga Fallach   +11 more
doaj   +1 more source

Sickle cell anaemia with and without crises: An observational study of pregnancy outcomes

open access: yesBritish Journal of Haematology, Volume 209, Issue 5, Page 2264-2272, November 2026.
Summary We assessed the pregnancy outcomes of patients with sickle cell crises. We carried out a retrospective study of 2 698 556 pregnancies in Quebec, Canada between 1989 and 2022. The primary exposure was sickle cell anaemia with crisis during or outside of pregnancy. Outcomes included severe maternal morbidity and other pregnancy complications.
Nathalie Auger   +8 more
wiley   +1 more source

Alloimmunization to low and high prevalence blood group antigens: rare causes of hemolytic disease of the fetus and newborn.

open access: yes
Maternal alloimmunization to paternal blood group antigens is the underlying cause of hemolytic disease of the fetus and newborn. Alloantibodies to the major, clinically significant blood group antigens are readily identified by the blood bank which, in ...
Blackall, Douglas P, Tomlinson, Mark W
core   +1 more source

Bronchopulmonary Dysplasia Starts in Utero: MicroRNA Dysregulation Across the Fetal–Neonatal Continuum in the Bronchopulmonary Dysplasia Development

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Bronchopulmonary dysplasia (BPD) is a heterogeneous developmental lung disorder resulting from the interaction between antenatal susceptibility and postnatal injury. Increasing evidence suggests that its biological origins may precede preterm birth, with placental dysfunction, fetal growth restriction, inflammation and oxidative stress ...
Serafina Perrone   +13 more
wiley   +1 more source

Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi Consensus

open access: yes
The study aimed to develop structured, expert-based clinical guidance on the prenatal and postnatal management of hemolytic disease of the fetus and newborn.
Sambatur, Enaja V   +4 more
core   +1 more source

Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies

open access: yesTransfusion, Volume 66, Issue 11, Page 2360-2372, November 2026.
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike   +33 more
wiley   +1 more source

AABB survey on directed blood donation practices

open access: yesTransfusion, Volume 66, Issue 11, Page 2233-2243, November 2026.
Abstract Background Standardized guidance regarding the processes for collecting directed blood donations (DBD) is lacking, leading to variable practices. This study assessed laboratory, clinical, and charging practices for DBD collection in the United States and Canada. Study Design and Methods An electronic survey was distributed to United States and
Nabiha H. Saifee   +6 more
wiley   +1 more source

Mapping obstetric biobanks: A scoping review highlighting gaps in the study of alloimmunized pregnancies

open access: yesTransfusion, Volume 66, Issue 11, Page 2373-2384, November 2026.
Abstract Background Maternal red cell alloimmunization can cause hemolytic disease of the fetus and newborn (HDFN), yet prediction of disease severity remains limited. Biobanks that link pregnancy biospecimens with clinical and laboratory data could accelerate translational research; however, the landscape of relevant obstetric biobanks has not been ...
Orlin Chowdhury   +10 more
wiley   +1 more source

Unexpected neonatal ABO discrepancy revealing ABO*cisAB.05 during routine cord blood testing

open access: yesTransfusion, Volume 66, Issue 11, Page 2496-2501, November 2026.
Abstract Background An apparent AB blood group in a neonate born to a group O mother can raise diagnostic, transfusion, and parentage‐sensitive concerns. CisAB alleles are rare ABO variants in which a single inherited allele encodes glycosyltransferase activity producing both A and B antigens.
Ali Ghais   +8 more
wiley   +1 more source

A distinctive RhD serologic phenotype expressed by p.Glu233Lys RHD alleles DV type 5 and DAU4 in microplate agglutination RhD typing

open access: yesTransfusion, Volume 66, Issue 11, Page 2116-2122, November 2026.
Abstract Background In patients with variant RhD phenotypes, serologic reactions for partial RHD genotypes are indistinguishable from other variants. Study Design and Methods In two US transfusion services, patients were typed for RhD by automated microplate RhD typing (Werfen, Norcross, GA) using two directly agglutinating IgM anti‐D reagents, MS201 ...
Vidyadhari Karne   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy